Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

8 823 evidences · page 122 / 353

0,095 μg/mLL'artémisinine extraite d'Artemisia annua inhibe Plasmodium falciparum à 50 % à une concentration de 0,095 μg/mL.

NigeriapaludismeHAL · Unilimdocument de 173 observations

12,1 %The prevalence rates for women and men were similar at 12.1%.

Nigeriaprediabetesobservé 2000–2019publié 2021Frontiers in public healthPubMeddocument de 7 observations

6,3 %Minor PI resistance-associated mutation N88D was identified in 6.3% of CRF02_AG HIV-1 isolates.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations

67,4 %67.4% of the patients had an SpO2 < 94% in ambient air when admitted.

NigeriaCOVID-19publié 2022West African journal of medicinePubMeddocument de 15 observations

10,4 %In Osun State, Nigeria, 10.4% of households did not hang their long-lasting insecticidal net (LLIN).

Nigeriapaludismepublié 2024Malaria journalPubMeddocument de 6 observations

24 %24.0% of women use the sulfadoxine/pyrimethamine prophylactic regimen for malaria in pregnancy in Ebonyi State.

Nigeriapaludismepublié 2019BMC pregnancy and childbirthPubMeddocument de 10 observations

89,3 %The respondents were highly open to cervical cancer screening (89.3%).

Nigeriacancer du col de l'utérusobservé April 2021publié 2024The Pan African medical journalPubMeddocument de 8 observations

168 hoursFollowing peak gametocytaemia, gametocytes persisted in blood for a period of 168–504 h in nine children with chloroquine-sensitive Plasmodium falciparum malaria.

Nigeriapaludismepublié 2003Parasite (Paris, France)europe_pmcdocument de 4 observationsDOI 10.1051/parasite/2003104363

4 %Of the 99 HIV-exposed infants (HEIs), 4 (4.0%) had missing HIV DNA PCR test results in the register.

NigeriaVIH/sidaobservé January 2018 to January 2019publié 2021Journal of tropical pediatricsPubMeddocument de 4 observations

788 samplesA total of 788 samples were collected from newly diagnosed HIV clients across 4 sites in Lagos and 3 sites in Benue between February and August 2018.

NigeriaVIH/sidaobservé 2018publié 2025BMC health services researchPubMeddocument de 7 observations

5,1 %The prevalence of patent parasitaemia among neonates was 5.1% in a prospective multi-centre study of 1875 consecutive mother-baby pairs in Nigeria.

Nigeriapaludismepublié 2007Tropical medicine & international health : TM & IHeurope_pmcdocument de 3 observations

3,81 %The prevalence of LSIL among HIV-positive females on HAART was 3.81%.

Nigerialow grade squamous intraepithelial lesion (LSIL)publié 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

7,2 %Among pregnant women in Jos, Nigeria, the prevalence of hepatitis B virus (HBV) was 7.2% among those without human immunodeficiency virus (HIV), during the period from 1 November 2017 to 30 April 2018.

Nigeriahépatite B · VIH/sidaobservé 1 November 2017 to 30 April 2018publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 3 observations

5 %Among 7,682 cancers treated among Lagos residents, prostate cancer accounted for 5%.

Nigeriacancer de la prostatepublié 2022JCO global oncologyPubMeddocument de 12 observations

24 daysMedian time to death was 24 days in HIV-infected subjects.

Nigeriacarcinome hépatocellulaire · VIH/sidapublié 2021Tropical medicine & international health : TM & IHPubMeddocument de 15 observations

CQ treatment of CQ-S infections resulted in significantly lower density of gametocytaemia on day 14 compared with day 0.

Nigeriapaludismepublié 2003Tropical medicine & international health : TM & IHeurope_pmcdocument de 5 observations

64,3 %The prevalence of viral suppression was 64.3% among 1120 HIV/AIDS-eligible patients in a tertiary health facility in Northwestern Nigeria between January and December 2021.

NigeriaVIH/sidaobservé 2021publié 2024Annals of African medicinePubMeddocument de 12 observations

17,4 %Artisans accounted for 17.4% of tuberculosis cases among 241 TB patients in a semi-urban tuberculosis center in Southeast Nigeria between September 2014 and August 2017.

Nigeriatuberculoseobservé September 2014 and August 2017publié 2021West African journal of medicinePubMeddocument de 10 observations

54 %At day 0, MPXV detection was less frequent from semen (13 [54%] of 24) than from skin, but more frequent than from blood, urine, or throat.

Nigeriampoxobservé day 0HAL · Unilimdocument de 102 observations

47,5 %Among pregnant women attending primary healthcare centres in Ile-Ife, Nigeria, 47.5% reported current utilisation of long-lasting insecticide nets (LLINs).

Nigeriapaludismepublié 2026Malaria journalPubMeddocument de 5 observations

46,7 %The most prevalent high-risk HPV type detected was HPV16 at 46.7%.

Nigeriahigh-risk HPVpublié 2025International journal of STD & AIDSPubMeddocument de 13 observations

68,5 %Low HDL-cholesterol was observed in 68.5% of participants in the Kabong community, Jos, north central Nigeria.

Nigerialow HDL-Cholesterolobservé 2017publié 2023West African journal of medicinePubMeddocument de 14 observations

5 casesAmong 35 suspected mpox cases in Rivers State, Nigeria, between October 21, 2021, and April 30, 2023, 5 (14.3%) had HIV infection.

Nigeriampox · VIH/sidaobservé October 21, 2021 to April 30, 2023publié 2025The Pan African medical journalPubMeddocument de 11 observations

24 250 vaccine_doses24,250 Mpox vaccine doses were prepared for shipment to the Democratic Republic of the Congo, Kenya, Nigeria, and Uganda.

Kenya · Nigeria · Ouganda · RDCmpoxAfrica CDCdocument de 72 observations

80 %80% of clinicians knew saliva could be used in diagnosing oral diseases.

Nigeriaoral diseasespublié 2019The Pan African medical journalPubMeddocument de 17 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.